Medicines in Development for Vaccines 2013

Medicines in Development for Vaccines 2013

America’s biopharmaceutical companies are currently developing 271 vaccines to prevent – and in some cases treat – a variety of conditions, including infectious diseases, various forms of cancer and neurological disorders, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA) 

For many years, vaccines have been used to successfully prevent devastating infectious diseases such as smallpox, measles and polio. According to data from the Centers for Disease Control and Prevention (CDC), 10 infectious diseases have been at least 90 percent eradicated in the United States as a result of vaccines. These innovations and subsequent immunization efforts have protected millions of children and families from needless illness.

“Biopharmaceutical research companies are working with partners across the ecosystem to apply new scientific approaches to the development of both preventative and therapeutic vaccines,” said PhRMA President and CEO John J. Castellani. “The nearly 300 vaccines in the pipeline provide great hope for protecting and improving public health in the United States and across the globe.”

More On PhRMA — powered by PhRMApedia